Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $109.65M.
ENTERPRISE VALUE (EV)
$109.65M
BGM Group Ltd.
Market Cap
$117.61M
Enterprise Value (EV)
$109.65M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BGM Group Ltd. (BGM) | $117.61M | $109.65M |
| Spruce Biosciences, Inc. (SPRB)vs › | $119.21M | $30.59M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.34M | $95.25M |
| Coya Therapeutics, Inc. (COYA)vs › | $115.61M | N/A |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.28M | $46.15M |
| Genelux Corporation (GNLX)vs › | $114.76M | $108.00M |
| Caribou Biosciences, Inc. (CRBU)vs › | $114.55M | $115.01M |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.52M | $106.03M |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | $113.16M |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | $116.29M |
Market Cap
$117.61M
Total Debt
$1.86M
Cash
$9.82M
Enterprise Value
$109.65M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
